Ilse Roodink
Chief Tech/Sci/R&D Officer chez IMMUNOPRECISE ANTIBODIES LTD.
Fortune : 14 504 $ au 31/03/2024
Profil
Ilse Roodink is currently the Chief Scientific Officer at ImmunoPrecise Antibodies Ltd.
She previously worked as the Scientific Director at Immunoprecise Antibodies (Europe) BV.
Dr. Roodink received her undergraduate, graduate, and doctorate degrees from Radboud University Nijmegen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 9 542 ( 0,04% ) | 14 504 $ | 31/03/2024 |
Postes actifs de Ilse Roodink
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Chief Tech/Sci/R&D Officer | 01/07/2021 |
Anciens postes connus de Ilse Roodink
| Sociétés | Poste | Fin |
|---|---|---|
Immunoprecise Antibodies (Europe) BV
 Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Formation de Ilse Roodink
| Radboud University Nijmegen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Health Technology |
